Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Carl Morrison?

Carl D. Morrison

Executive Director of the Center for Personalized Medicine

Roswell Park Cancer Institute

HQ Phone:  (716) 845-2300

Direct Phone: (716) ***-****direct phone

Email: c***@***.org

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Roswell Park Cancer Institute

666 Elm Street

Buffalo, New York,14263

United States

Company Description

About Roswell Park Cancer Institute The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. Founded in 1898, RPCI is one of the first cancer centers in the country to be named a National Cancer Institute-designated compre...more

Background Information

Employment History

President, Founder

OmniSeq LLC


President

CSO


Assistant Professor of Pathology

The Ohio State University Medical Center


Affiliations

Association for Molecular Pathology

Member


College of American Pathologists

Member


New York Genome Center

Board Member


OSU Medical Center

Faculty Member


American Society for Investigative Pathology

Member


American College of Pathology

Member


Canadian Academy of Pathology

Member


Education

DVM


Doctorate in Medicine

University of Kentucky


Doctorate in Veterinary Medicine

The Ohio State University College of Veterinary Medicine


MD

Roswell Park Cancer Institute


MD

Wilmot Cancer Institute


Web References(67 Total References)


Leadership - www.omniseq.com

www.omniseq.com [cached]

Carl Morrison, MD, DVM
Carl Morrison, MD, DVM President, CSO and Founder Dr. Morrison is OmniSeq's Founder and Chief Scientific Officer. Dr. Morrison is a board-certified pathologist and Executive Director of the Center for Personalized Medicine at Roswell Park Cancer Institute (RPCI) in Buffalo, New York. Dr. Morrison is a Professor and Program Member in Cancer Genetics at RPCI and was recently awarded Roswell Park's prestigious Thomas B. Tomasi Hope Award for his contribution to cancer research. Recognized nationally for his work in translational medicine, Dr. Morrison has authored or co-authored more than 100 peer-reviewed manuscripts with a focus on molecular pathology. His work has been published in many leading journals, including Nature, the Journal of Clinical Oncology, and Cancer Research. Dr. Morrison is a Member of the College of American Pathologists and the Association for Molecular Pathology. Carl Morrison, MD, DVM - President, Chief Scientific Officer, Founder Carl Morrison is a board-certified pathologist, who developed the vision for OmniSeq while leading the Center for Personalized Medicine and Division of Molecular Pathology at RPCI.


cancerletter.com

CLEP is the highest standard of Clinical Laboratory Improvement Amendments laboratory validation," said Carl Morrison, president and chief scientific officer of OmniSeq and executive director of the Roswell Park Center for Personalized Medicine.


www.personalizedmedicinepartnerships.com

In this talk Dr. Morrison will present an overview of the implementation of NGS into the clinical practice at one of the leading comprehensive cancer centers, Roswell Park Cancer Institute.
He will discuss strategies that begin with defining the panel of genes to be tested, optimal design of infrastructure to validate and deliver such testing, to the final process of engaging payers and gaining reimbursement. In the end "the $1,000 dollar genome" will meet the reality of the overall investment across the continuum of this process. Carl Morrison, MD, DVM, Executive Director of the Center for Personalized Medicine, Clinical Chief, Department of Pathology & Laboratory Medicine, Director, Division of Molecular Pathology, Director, Pathology Resource Network, Roswell Park Cancer Institute


Roswell Park Cancer Institute | Buffalo Niagara Enterprise Blog | Economic Development Discussions

blog.buffaloniagara.org [cached]

Dr. Carl Morrison in Roswell Park Center for Personalized Medicine
Dr. Carl Morrison in Roswell Park Center for Personalized Medicine Dr. Carl Morrison is founder, president and chief scientific officer of OmniSeq LLC - a recent Roswell Park Cancer Institute spinoff genomics firm. At Roswell Park, Dr. Morrison continues in his roles as Executive Director of the Center for Personalized Medicine, Clinical Chief of the Pathology & Laboratory Medicine Department, Director of the Molecular Pathology Division, Director of the Pathology Resource Network and Professor of Oncology. I recently had the opportunity to ask Dr. Morrison a few questions: And my family is happy and thriving here. - Dr. Carl Morrison


www.nextgenerationdx.com

Carl Morrison
Carl Morrison, M.D., DVM, Executive Director, Center for Personalized Medicine; Director, Roswell Park Cancer Institute Prior models of revenue streams for laboratories have been almost exclusively from 3rd party payers for laboratory services provided. As laboratories move from traditional single analyte testing to comprehensive multi-analyte platforms the ability to generate 2nd and 3rd uses of this data has the ability to generate additional revenue streams. Dr. Morrison will present how his group is using this new business model to achieve new avenues of commercialization for laboratory testing through the OmniSeq program. Carl Morrison, M.D., DVM, Executive Director, Center for Personalized Medicine; Director, Roswell Park Cancer Institute


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory